Pharmacokinetic/Pharmacodynamic Modeling of IVIG Effects in a Murine Model of Immune Thrombocytopenia

This publication has 29 references indexed in Scilit:

• Mechanisms of Intravenous Immunoglobulin Action in Immune Thrombocytopenic Purpura
  Human Immunology, 2005
• Generation of Mutated Variants of the Human Form of the MHC Class I-related Receptor, FcRn, with Increased Affinity for Mouse Immunoglobulin G
  Journal of Molecular Biology, 2003
• Pharmacokinetic/Pharmacodynamic Modeling of the Effects of Intravenous Immunoglobulin on the Disposition of Antiplatelet Antibodies in a Rat Model of Immune Thrombocytopenia
  Journal of Pharmaceutical Sciences, 2003
• The mechanism of action of high-dose IgG in idiopathic thrombocytopenic purpura
  Blood, 2002
• Effects of intravenous immunoglobulin on platelet count and antiplatelet antibody disposition in a rat model of immune thrombocytopenia
  Blood, 2002
• Intravenous Immunoglobulin Mediates an Increase in Anti-Platelet Antibody Clearance via the FcRn Receptor
  Thrombosis and Haemostasis, 2002
• Differences in promiscuity for antibody–FcRn interactions across species: implications for therapeutic antibodies
  International Immunology, 2001
• Finally! the Brambell receptor (FcRB)
  Immunologic Research, 1997
• Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology [see comments]
  Blood, 1996
• HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD
  The Lancet, 1981